China has granted emergency approval to its first-ever antibody cocktail therapy against Covid-19, which has shown to be effective in reducing the risk of hospitalisation or death among high-risk Covid-19 patients by 80 per cent, the media ...
Related Keywords
Brazil , Mexico , Philippines , Argentina , Shenzhen , Guangdong , China , Beijing , South Africa , Zhang Linqi , Brii Biosciences , Tsinghua School Of Medicine , National Medical Products Administration , Tsinghua University , Global Times , Third People , Drug Administration ,
vimarsana.com © 2020. All Rights Reserved.